BIIB vs MRK
BIIB and MRK side by side — valuation & fundamentals (public data).
Key statistics
| Metric | BIIBBIOGEN INC. | MRKMerck & Co., Inc. |
|---|---|---|
| Market cap | $37.49B | $368.94B |
| P/E (TTM) | 109.8 | 119.6 |
| P/B | 2.53 | 8.80 |
| P/S | 3.8x | 5.7x |
| Dividend yield | — | 2.22% |
| Revenue | $10.30B(TTM) | $66.57B(TTM) |
| Revenue growth (YoY) | 2.2% | 1.3% |
| Net income | $347.60M(TTM) | $3.17B(TTM) |
| Earnings growth (YoY) | -20.8% | 6.6% |
| EPS, diluted | $2.31(TTM) | $1.25(TTM) |
| EBIT margin | 28.7% | 34.2% |
| ROE | 8.7% | 43.5% |
| ROIC | 12.3% | 21.6% |
| Piotroski F | 3/9 | — |
| 1y total return | +69.6% | +77.1% |
Figures from SEC filings · for reference only · not investment advice
Crecimiento de $10,000: BIIB frente a MRK
| Métrica | BIIB | MRK |
|---|---|---|
| Valor final | $10.6K | $35.8K |
| Retorno total | +6.2% | +258.2% |
| CAGR | +0.6% | +13.1% |
| Volatilidad | 41.1% | 23.4% |
| Sharpe | 0.11 | 0.47 |
| Sortino | 0.18 | 0.69 |
| Caída máxima | -72.7% | -43.4% |
Basado en 2600 días de negociación comunes, 2016-06-29 → 2026-10-30 · tasa libre de riesgo 4.16% (bono corto del Tesoro actual, mantenido constante)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
Related comparisons
Delayed data · Public sources · For reference only · Not investment advice (this page declares no winner)